DE69331231D1 - Ein neuartiges, antineoplastisches cytokin - Google Patents

Ein neuartiges, antineoplastisches cytokin

Info

Publication number
DE69331231D1
DE69331231D1 DE69331231T DE69331231T DE69331231D1 DE 69331231 D1 DE69331231 D1 DE 69331231D1 DE 69331231 T DE69331231 T DE 69331231T DE 69331231 T DE69331231 T DE 69331231T DE 69331231 D1 DE69331231 D1 DE 69331231D1
Authority
DE
Germany
Prior art keywords
oncoinhibin
cytokin
antineoplastic
new
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331231T
Other languages
English (en)
Other versions
DE69331231T2 (de
Inventor
Bharat Aggarwal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Application granted granted Critical
Publication of DE69331231D1 publication Critical patent/DE69331231D1/de
Publication of DE69331231T2 publication Critical patent/DE69331231T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69331231T 1992-04-24 1993-04-23 Ein neuartiges, antineoplastisches cytokin Expired - Fee Related DE69331231T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/874,308 US5241051A (en) 1992-04-24 1992-04-24 Oncoinhibin
PCT/US1993/003828 WO1993022346A1 (en) 1992-04-24 1993-04-23 A novel anti-neoplastic cytokine

Publications (2)

Publication Number Publication Date
DE69331231D1 true DE69331231D1 (de) 2002-01-10
DE69331231T2 DE69331231T2 (de) 2002-08-22

Family

ID=25363462

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331231T Expired - Fee Related DE69331231T2 (de) 1992-04-24 1993-04-23 Ein neuartiges, antineoplastisches cytokin

Country Status (18)

Country Link
US (1) US5241051A (de)
EP (1) EP0637319B1 (de)
JP (1) JP3434511B2 (de)
KR (1) KR950701347A (de)
CN (1) CN1068335C (de)
AT (1) ATE209500T1 (de)
AU (1) AU671637B2 (de)
CA (1) CA2118498C (de)
DE (1) DE69331231T2 (de)
FI (1) FI112081B (de)
IL (1) IL105473A (de)
NO (1) NO313099B1 (de)
NZ (1) NZ252429A (de)
RU (1) RU2139087C1 (de)
SA (1) SA93140393B1 (de)
TW (1) TW372873B (de)
WO (1) WO1993022346A1 (de)
ZA (1) ZA932830B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993798A (en) * 1992-04-24 1999-11-30 Research Development Foundation Oncoinhibin and methods of pharmaceutical use
IL126442A0 (en) * 1996-04-03 1999-08-17 Rogosin Inst Implantable agarose-collagen beads containing cells which produce a diffusible biological product and uses thereof
SG10201912629UA (en) * 2012-01-18 2020-02-27 Biosuccess Biotech Co Ltd Compositions and methods of use of phorbol esters
CN116041514A (zh) 2016-06-06 2023-05-02 希望之城 Baff-r抗体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
IL94055A (en) * 1989-04-10 1995-11-27 Oncogen Oncostatin M Container Pharmaceuticals to Change Tissue Immunogenicity and Improve Implant Absorption

Also Published As

Publication number Publication date
FI944907A0 (fi) 1994-10-19
AU671637B2 (en) 1996-09-05
EP0637319A4 (de) 1997-06-11
JP3434511B2 (ja) 2003-08-11
CA2118498A1 (en) 1993-11-11
ATE209500T1 (de) 2001-12-15
IL105473A0 (en) 1993-08-18
DE69331231T2 (de) 2002-08-22
FI944907A (fi) 1994-10-19
IL105473A (en) 1998-09-24
WO1993022346A1 (en) 1993-11-11
JPH07506364A (ja) 1995-07-13
ZA932830B (en) 1994-11-22
EP0637319B1 (de) 2001-11-28
AU4113593A (en) 1993-11-29
NO943968L (no) 1994-10-19
SA93140393B1 (ar) 2006-05-23
CN1068335C (zh) 2001-07-11
KR950701347A (ko) 1995-03-23
TW372873B (en) 1999-11-01
CN1083389A (zh) 1994-03-09
RU2139087C1 (ru) 1999-10-10
EP0637319A1 (de) 1995-02-08
NO943968D0 (no) 1994-10-19
RU94045922A (ru) 1997-05-10
NO313099B1 (no) 2002-08-12
FI112081B (fi) 2003-10-31
US5241051A (en) 1993-08-31
NZ252429A (en) 1996-06-25
CA2118498C (en) 2005-06-21

Similar Documents

Publication Publication Date Title
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
DK0503035T3 (da) Hidtil ukendt 1alfa-hydroxy-vitamin D4 og hidtil ukendte mellemprodukter og analoger
ES515032A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
BR9004922A (pt) Protese de valvula cardiaca
DE69012800T2 (de) Hüftprothese.
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
IT8026127A0 (it) Nuovo procedimento per la preparazione di 4' epidaunorubicina 3, 4diepidaunorubicina e corrispondenti analoghi della doxorubicina
IT1231549B (it) Procedimento per la produzione di semilavorati di cuoio
IT1229144B (it) Procedimento per la produzione di carbammati.
ES1011643Y (es) Mesa elevadora para correccion de la pelvis..
DE69331231D1 (de) Ein neuartiges, antineoplastisches cytokin
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2071004T3 (es) Nuevos peptidos, su uso para inhibir la maduracion de linfocitos t y la actividad de macrofagos, y procesos para su preparacion.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
CS326486A2 (en) Method of 17-alpha-phenyl-17-beta-hydroxy-18-methyl-4,15-oestradien-3-on' production
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
DK189285D0 (da) (6,11-dihydro-11-oxodibenz(b,e)oxepinyl)-pentancarboxylsyrer, deres fremstilling og anvendelse
IT9067138A1 (it) Procedimento per la preparazione di alfa-alchil lattoni.
ES542554A0 (es) Un procedimiento para preparar (6,11-dihidro-11-oxodibenznb,e)oxepinil)pentanoles
ES2042572T3 (es) Procedimiento e intermedios para la obtencion de n-(s-3-alquilheptanoil)-d-gamma-glutamil-glicil-d-alanina.
ES1010441Y (es) Mesa para la practica de lucha de brazos.
IT1230745B (it) Procedimento per la preparazione di n fosfonometilglicina.
IT8920041A0 (it) Procedimento per la produzione di isocianati.
IT8919405A0 (it) Procedimento per la preparazione di pentaclorotiofenolo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee